Another early study done in breast cancer mouse model showed that metformin treatment significantly decreased the tumor burden and accumulation of mammary adenocarcinomas accompanied by increase in the life span of HER-2/neu transgenic mice [70]. This evidence concerns the gene ERBB2 and breast adenocarcinoma.